Vectura News

Discover more about our company, science, innovation and people with the latest headlines from Vectura.

Displaying 12 of 64

Status update on VR315 (US)

Published22/09/2020

Read more
2020 Interim Results

Published15/09/2020

Read more
Vectura partners with Monash University to support development of inhaled oxytocin to prevent postpartum haemorrhage

Published14/09/2020

Read more
Notice of Interim Results

Published06/08/2020

Read more
QVM149 receives regulatory approval in Europe and Japan

Published07/07/2020

Read more
Live Webcast 24th June: Dry Powder Inhalers – Key Considerations for Combination Product Development

Published17/06/2020

Read more
Vectura signs agreement with Aerami Therapeutics Inc.

Published08/06/2020

Read more
Vectura expands business development team with three global appointments

Published03/06/2020

Read more
Podcast: Breathing new life into existing drugs

Published28/05/2020

Read more
Share buyback and AGM trading update

Published27/05/2020

Read more
Podcast: Vectura presents latest science at Digital RDD 2020

Published17/04/2020

Read more
Vectura’s response to the COVID-19 outbreak

Published19/03/2020

Read more

Displaying 12 of 64